Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Bechem Chemicals was a China-based pharmaceutical chemicals company focused on the development, production, and marketing of active pharmaceutical ingredients, pharmaceutical intermediates, and natural plant extracts. The company described itself as a high-tech enterprise integrating R&D, manufacturing, and export activities, with product coverage spanning cardiovascular and cerebrovascular disease, endocrine, digestive, neurology, oncology, anti-infective, and antiviral areas. Public supplier profiles indicate capabilities in chemosynthesis, analytical testing, pilot-scale work, and GMP-aligned manufacturing, including a newer factory project in Qihe Economic Development Zone. The business appears to have operated primarily as an API/intermediates supplier rather than a drug developer with a clinical pipeline. Chinese business registry records indicate the legal entity was deregistered in December 2021.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Bechem Chemicals.